-
Signature
-
David Kwon (POA on File)
-
Stock symbol
-
ADP
-
Transactions as of
-
Sep 9, 2024
-
Transactions value $
-
-$7,959,926
-
Form type
-
4
-
Date filed
-
9/11/2024, 04:06 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADP |
Common Stock |
Options Exercise |
$1.58M |
+11.4K |
+36.3% |
$138.53 |
42.9K |
Sep 9, 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Options Exercise |
$1.6M |
+7.72K |
+17.99% |
$206.86 |
50.6K |
Sep 9, 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
-$2.08M |
-7.72K |
-15.25% |
$269.70 |
42.9K |
Sep 9, 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
-$2.8M |
-10.4K |
-24.16% |
$269.70 |
32.5K |
Sep 9, 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
-$3.08M |
-11.4K |
-35.12% |
$269.70 |
21.1K |
Sep 9, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
-$1.58M |
-11.4K |
-100% |
$138.53 |
0 |
Sep 9, 2024 |
Common Stock |
11.4K |
$138.53 |
Direct |
|
| transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
-$1.6M |
-7.72K |
-33.33% |
$206.86 |
15.4K |
Sep 9, 2024 |
Common Stock |
7.72K |
$206.86 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: